Ceftaroline as salvage therapy for methicillin susceptible staphylococcus aureus complicated bacteremia

Obed, Mora N.; Toresani, Inés; Mykietuk, Analía; Nannini, Esteban C..
Medicina (B.Aires) ; 82(5): 794-797, Oct. 2022. graf
Artículo en Inglés | LILACS-Express | ID: biblio-1405742

Documentos relacionados

  1. Ceftaroline as salvage therapy for methicillin susceptible Staphylococcus aureus complicated bacteremia.
  2. Daptomycin Plus Oxacillin for Persistent Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia.
  3. Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial.
  4. Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia.
  5. Tolerability of Cefazolin in Nafcillin-Intolerant Patients for the Treatment of Methicillin-Susceptible Staphylococcus aureus Infections.
  6. Therapeutic Options for Adult Patients With Persistent Methicillin-Susceptible <i>Staphylococcus aureus</i> Bacteremia: A Narrative Review.
  7. Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia.
  8. Cefazolin plus ertapenem and heart transplantation as salvage therapy for refractory LVAD infection due to methicillin-susceptible Staphylococcus aureus: A case series.
  9. Safety and Efficacy of Ceftriaxone in the Treatment of Methicillin-Susceptible <i>Staphylococcus aureus</i> Bloodstream Infections: A Noninferiority Retrospective Cohort Study.
  10. Interventions to treat methicillin-susceptible Staphylococcus aureus bacteremia: many methodological concerns.